Biocept Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 95
Employees
  • Stock Symbol
  • BIOC
Stock Symbol
  • Share Price
  • $0.72
  • (As of Thursday Closing)

Biocept General Information

Description

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 5810 Nancy Ridge Drive
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocept Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.72 $0.67 $0.21 - $1.09 $94.3M 131M 26.2M -$0.94

Biocept Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 22,046 8,669 (3,875) 20,485
Revenue 5,951 5,529 3,250 5,069
EBITDA (26,535) (24,115) (23,458) (20,548)
Net Income (27,563) (25,138) (24,572) (21,614)
Total Assets 29,812 17,733 8,750 7,379
Total Debt 2,309 2,540 1,627 2,789
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biocept Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biocept‘s full profile, request access.

Request a free trial

Biocept Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes propriet
Laboratory Services (Healthcare)
San Diego, CA
95 As of 2019
00000
000000000 00000

00000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000000000 000000000
Redwood City, CA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000

000000 0

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000000 00000000 (0000000000)
Rutherford, NJ
000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biocept Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guardant Health Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
000000 00000000 Formerly VC-backed Rutherford, NJ 000 000.00 00000000000 000.00
000000 000000 Venture Capital-Backed South Plainfield, NJ 00 00000000000
000 000 00000000 Corporate Backed or Acquired Cologne, Germany 00 000000&0
0000000000 Venture Capital-Backed Pittsburgh, PA 00 00.00 00000000000 00.00
You’re viewing 5 of 15 competitors. Get the full list »

Biocept Executive Team (17)

Name Title Board Seat Contact Info
Michael Nall Chief Executive Officer & Board Member
Timothy Kennedy Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Lyle Arnold Ph.D Chief Scientific Officer & Senior Vice President
Hendrick Edwin Executive & Senior Vice President
Edwin Hendrick Senior Vice President & Chief Commercial Officer
You’re viewing 5 of 17 executive team members. Get the full list »

Biocept Board Members (17)

Name Representing Role Since
Bruce Gerhardt Self Board Member 000 0000
Bruce Huebner Self Board Member 000 0000
David Hale Self Chairman of the Board 000 0000
Faye Wilson Biocept Board Member & Chairman of Audit Committee 000 0000
Hae Moon Park Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Biocept Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocept Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biocept‘s full profile, request access.

Request a free trial